SCHEMBL4457723

SCHEMBL4457723

Nc1ncc(-c2cc(C3CC3)[nH]n2)c(N)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.43
HCAR3 P49019 1/20 0.43
MKNK1 Q9BUB5 5/20 0.42
MKNK2 Q9HBH9 5/20 0.42
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPK1 P28482 1/20 0.40
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28664537 0.94 MKNK1 (0.40) HCAR2HCAR3MKNK1MKNK2KMT2A
SCHEMBL27964125 0.87 HCAR2 (0.49) HCAR2HCAR3MKNK1MKNK2KMT2A
SCHEMBL28649163 0.86 PIK3CA (0.40) HCAR2HCAR3MKNK1MKNK2KMT2A
SCHEMBL27976878 0.85 MKNK1 (0.35) HCAR2HCAR3MKNK1MKNK2KMT2A
SCHEMBL14722563 0.82 IGF1R (0.40) HCAR2HCAR3MKNK1MKNK2KMT2A
SCHEMBL28814284 0.81 PIK3CA (0.35) MKNK1MKNK2ADORA2AADORA1PIK3CA
SCHEMBL27983380 0.81 PIK3CA (0.35) MKNK1MKNK2ADORA2AADORA1PIK3CA
SCHEMBL27983385 0.81 PIK3CA (0.35) MKNK1MKNK2ADORA2AADORA1PIK3CA
SCHEMBL15058709 0.79 IGF1R (0.54)
SCHEMBL27983094 0.77 DHFR (0.40) SMN1; SMN2ADORA2AADORA1NPSR1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
EP-2794605-A1 2, 4-DIAMINE-PYRIMIDINE DERIVATIVE AS SERINE/THREONINE KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2014-10-29 EP disclosed
CN-104011050-A 2, 4-diamino-pyrimidine derivatives as serine/threonine kinase inhibitors HOFFMANN LA ROCHE 2014-08-27 CN disclosed
EP-2748159-A1 SERINE/THREONINE PAK1 INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2014-07-02 EP disclosed
WO-2013092940-A1 2, 4-DIAMINE-PYRIMIDINE DERIVATIVE AS SERINE/THREONINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2013-06-27 WO disclosed
WO-2013026914-A1 SERINE/THREONINE PAK1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2013-02-28 WO disclosed